Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP12 | P39900 | 7/20 | 0.34 |
| ▸ | MMP13 | P45452 | 6/20 | 0.34 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | MMP9 | P14780 | 1/20 | 0.33 |
| ▸ | MMP14 | P50281 | 1/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.32 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.30 |
| ▸ | CTSA | P10619 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4614540 | 0.74 | MMP12 (0.41) | MMP12MMP13SLC22A6MMP2MMP9 | |
| SCHEMBL4403318 | 0.73 | MMP12 (0.47) | MMP12MMP13 | |
| SCHEMBL1138918 | 0.68 | KDM4E (0.49) | MMP12MMP13MMP2MMP9MMP14 | |
| SCHEMBL4748340 | 0.67 | MMP12 (0.54) | MMP12MMP13MMP2MMP9MMP14 | |
| SCHEMBL8502656 | 0.67 | DAO (0.33) | SLC22A6GABRR1CTSALMNA | |
| SCHEMBL665776 | 0.67 | MMP12 (0.54) | MMP12MMP13MMP2MMP9MMP14 | |
| SCHEMBL1138961 | 0.66 | GRM2 (0.46) | MMP12MMP13MMP2MMP9MMP14 | |
| SCHEMBL4612959 | 0.66 | GPR84 (0.41) | MMP12MMP13SLC22A6MMP2MMP9 | |
| SCHEMBL6403901 | 0.64 | SLC22A6 (0.57) | MMP12MMP13SLC22A6MMP2MMP9 | |
| SCHEMBL3947736 | 0.64 | MMP12 (0.44) | MMP12MMP13MMP2MMP9MMP14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7615233-B2 | Particulate construct comprising polyhydroxyalkanoate and method for producing it | CANON KABUSHIKI KAISHA (JP) | 2009-11-10 | — | — | US | disclosed |
| US-7527809-B2 | Polyhydroxyalkanoate-containing magnetic structure, and manufacturing method and use thereof | CANON KABUSHIKI KAISHA (JP) | 2009-05-05 | — | — | US | disclosed |
| EP-1275378-B1 | Particulate construct comprising polyhydroxyalkanoate and method for producing it | CANON KK (JP) | 2009-04-15 | — | — | EP | disclosed |
| US-7408017-B2 | Polyhydroxyalkanoate containing unit with phenylsulfanyl structure in the side chain, process for its production, charge control agent, toner binder and toner which contain novel polyhydroxyalkanoate, and image forming method and image-forming apparatus which make use of the toner | CANON KABUSHIKI KAISHA (JP) | 2008-08-05 | — | — | US | disclosed |
| US-20060263432-A1 | Useful as a sustained release pharmaceutical preparation; microcapsule stably containing a drug, especially a water-soluble drug at high content and which has magnetic property; drug delivery; excellent in dispersibility and magnetic response | CANON KABUSHIKI KAISHA (JP) | 2006-11-23 | — | — | US | disclosed |
| US-20050250191-A1 | Novel polyhydroxyalkanoate containing unit with phenylsulfanyl structure in the side chain, process for its production, charge control agent, toner binder and toner which contain novel polyhydroxyalkanoate, and image forming method and image-forming apparatus which make use of the toner | CANON KABUSHIKI KAISHA (JP) | 2005-11-10 | — | — | US | disclosed |
| WO-2004096188-A1 | POLYHYDROXYALKANOATE-CONTAINING MAGNETIC STRUCTURE, AND MANUFACTURING METHOD AND USE THEREOF | CANON KABUSHIKI KAISHA (JP) | 2004-11-11 | — | — | WO | disclosed |
| US-20030194443-A1 | Particulate construct comprising polyhydroxyalkanoate and method for producing it | CANON KABUSHIKI KAISHA (JP) | 2003-10-16 | — | — | US | disclosed |
| US-20030013841-A1 | Novel polyhydroxyalkanoate containing unit with phenylsulfanyl structure in the side chain, process for its production, charge control agent, toner binder and toner which contain novel polyhydroxyalkanoate, and image-forming method and image-forming apparatus which make use of the toner | CANON KABUSHIKI KAISHA (JP) | 2003-01-16 | — | — | US | disclosed |
| EP-1275378-A2 | Particulate construct comprising polyhydroxyalkanoate and method for producing it | CANON KABUSHIKI KAISHA (JP) | 2003-01-15 | — | — | EP | disclosed |
| EP-1236755-A2 | Novel polyhydroxyalkanoate containing unit phenylsulfanyl structure in the side cahin, process for its production, charge control agent, toner binder and toner which contain novel polyhydroxyalkanoate, and imageforming apparatus which make use of the toner | CANON KABUSHIKI KAISHA (JP) | 2002-09-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030194443-A1 | Particulate construct comprising polyhydroxyalkanoate and method for producing it | SQLE, FDFT1, CYP51A1 | MMP12 2452/4885MMP13 3300/4885SLC22A6 1964/4885 |
| US-20060263432-A1 | Useful as a sustained release pharmaceutical preparation; microcapsule stably containing a drug, especially a water-soluble drug at high content and which has magnetic property; drug delivery; excellent in dispersibility and magnetic response | SKP1, HAMP, AUP1 | MMP12 1385/4885MMP13 2546/4885SLC22A6 1857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.